Come up with a name for your new list and we'll add to it:
Anabasis was acquired by
Dompe Farmaceutici on February 29, 2012.
Anabasis is a private biopharmaceutical company dedicated to the development of therapies for the eye. The company's initial focus is NGF (Nerve Growth Factor) for the treatment of diseases affecting …